JPRN-UMIN000004409已完成未知
A Pilot Study of TSB-002 for the Treatment of Atrial Fibrillation - A Pilot Study of TSB-002 for the Treatment of Atrial Fibrillation
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •left atrium >= 50 mm. amiodarone within six months. undergone previous LA ablation or surgical treatment for AF. LVEF< 35%. NYHA Class III or IV. history of MI or unstable angina. non-revascularized left main or >= 3-vessel coronary artery disease. severe mitral valve regurgitation or stenosis and is not an appropriate candidate for valvular intervention. left atrial thrombus. left atrial appendage occlusion device. severe obstructive carotid artery disease. hypertrophic cardiomyopathy with severe left ventricular outflow tract obstructions. severe pulmonary arterial hypertension. artificial heart valve. pacemaker and or ICD. history of cerebrovascular disease. severe aortic stenosis. IVC filter. DVT. significant renal failure. known history of a bleeding disorder. unable to take warfarin. abnormal thyroid function. allergy to iodine or iodine type of contrast media. active malignancy of any kind. pregnant or lactating. participated in another clinical research study within 3 months. judged to be unsuitable for participation.
研究者
相似试验
进行中（未招募）
不适用
A Clinical Trial of ABT-888 in Combination with Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Subjects with Recurrent High Grade Serous Ovarian CancerRecurrent high grade serous ovarian cancer.MedDRA version: 13.1Level: PTClassification code 10066697Term: Ovarian cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-015082-31-GBAbbott GmbH & Co. KG150
进行中（未招募）
不适用
A Clinical Trial of ABT-888 in Combination with Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Subjects with Recurrent High Grade Serous Ovarian CancerEUCTR2009-015082-31-HUAbbott GmbH & Co. KG150
已完成
不适用
A Pivotal Study of TSB-002C for the Treatment of Paroxysmal Atrial FibrillatioParoxysmal atrial fibrillationJPRN-UMIN000008439Toray Industries, Inc.111
进行中（未招募）
不适用
Abiraterone acetate in Molecular Apocrine breast cancerMolecular apocrine locally advanced or metastatic breast cancerMedDRA version: 14.1Level: PTClassification code 10006187Term: Breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-002525-29-FRICANCER
进行中（未招募）
不适用
Phase I/II Study of Combined Treatment with AT-101, Cisplatin and Radiotherapy in Patients with Locally Advanced Head and Neck CancerEUCTR2007-006120-36-NL50